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Pheochromocytomas and paragangliomas occur sporadi-
cally but are commonly associated with the von Hippel
Lindau (VHL) syndrome, multiple endocrine neoplasia
type 2 (MEN2), neurofibromatosis type 1 (NF1) and
germline mutations of succinate dehydrogenase B
(SDHB), C (SDHC) or D (SDHD). It is therefore recom-
mended that genetic testing be considered if not per-
formed in all cases of even apparently sporadic
pheochromocytomas or paragangliomas. Recently it has
been demonstrated that immunohistochemistry (IHC)
for SDHB is negative in all SDH mutated paraganglio-
mas regardless of whether the B,C or D subunit is
involved [1,2]. Furthermore some clearly syndromic
paragangliomas without known genetic mutation
(including but not limited to those which occur in the
Carney Triad) are identified by negative staining for
SDHB [3].
Although historically the renal tumours occurring in
the setting of SDHB mutation were usually classified
as conventional clear cell carcinoma or oncocytoma,
they actually display a unique morphology (unrecog-
nized until know) and which can be confirmed by
immunohistochemistry.
The GISTs occurring in SDH mutation and Carney
Triad are also unique and demonstrate quite a different
morphology, natural history and molecular pathogenesis
compared to other GISTs occurring in adults (but simi-
lar to most GISTs occurring in childhood). We call this
unique subtype of GIST the type 2 GIST. Briefly type 2
GISTs arise in the stomach, show an epithelioid mor-
phology, are often multifocal, commonly show lymph
node metastasis, are wild type for KIT and PDGFR, have
a prognosis not predicted by size and mitotic rate, never
respond to imatinib but demonstrate an indolent growth
despite the presence of frequent metastases [3,5].
We recommend that all paragangliomas, GISTs which
potentially display type 2 morphological or clinical fea-
tures and renal carcinomas which display the unique
morphology we described should undergo immunohisto-
chemistry for SDHB. Negative staining for SDHB indi-
cates an abnormality of the mitochondrial complex 2
and is an absolute indication for formal genetic testing.
We perform and interpret SDHB immunohistochemistry
of archived formalin fixed paraffin embedded tissue in a
manner analogous to MSI testing in colon cancer. In
the setting of paraganglioma or renal carcinoma nega-
tive staining almost always indicates germline SDHB,
SDHC or SDHD mutation (greater than 90% chance)
but may indicate Carney Triad. In the setting of GIST,
Carney Triad is more likely, but SDHB, SDHC or
SDHD mutation accounts for at least 25% of type 2
GIST.
The mitochondrial complex 2 links the Krebs cycle
and the electron transport chain and is illustrated below:
Published: 12 April 2012
References
1. van Nederveen FH, Gaal J, Favier J, et al: An immunohistochemical
procedure to detect patients with paraganglioma and
phaeochromocytoma with germline SDHB, SDHC or SDHD gene
mutations: a retrospective and prospective analysis. Lancet Oncol 2009,
10:764-771.
2. Gill AJ, Benn DE, Chou A, Clarkson A, Muljono A, Meyer-Rochow G,
Richardson A-L, Sidhu SB, Robinson BG, Clifton-Bligh RJ:
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC
and SDHD in paraganglioma-phaeochromocytoma syndromes. Hum
Pathol 2010, 41:805-814.
3. Gill AJ, Chou A, Vilain R, Clarkson A, Lui M, Jin R, Tobias V, Samra J,
Goldstein D, Smith C, Sioson L, Parker N, Smith RC, Sywak M, Sidhu SB, Ma
Correspondence: affgill@med.usyd.edu.au
Royal North Shore Hospital, Australia
Gill Hereditary Cancer in Clinical Practice 2012, 10(Suppl 2):A7
http://www.hccpjournal.com/content/10/S2/A7
© 2012 Gill; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Table 1 Syndromes associated with paraganglioma and pheochromocytoma
Syndrome Gene Incidence Clinical syndrome
Von Hippel-Lindau syndrome VHL(3p25) 1 in 36000 Retinal/CNS Hemangioblastoma





Epidymal/broad ligament papillary cystadenomas
Multiple endocrine neoplasia type 2 RET(10q11.2) 2.5 per 100 000 Medullary thyroid carcinoma
Phaeochromocytomas
Parathyroid hyperplasia
Neurofibromatosis type 1 NF1(17q11.2) 1 in 3000 Neurofibromas
Café au lait spors
Gliomas
Lisch Nodules
Paraganglioma Syndrome type 1 (PGL1) SDHD(11q23) ??? Pheochromocytomas/Paragangliomas
Most common locations:






Paraganglioma Syndrome Type 2 ??SDHAF2(11q13.1) Extremely Rare Head and neck paragangliomas
Paraganglioma Syndrom Type 3 (PGL3) SDHC(1q21-23) ??? (Rare) Head and neck paragangliomas
Renal tumours
Type 2 GIST
Paraganglioma Syndrome Type 4 (PGL4) SDHB(1p35-36) ??? Pheochromocytomas/Paragangliomas








Carney Triad No known familial case
No known mutation
Extremely rare 1.Paragagnlioma
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